Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MMS vs CACI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MMS
Maximus, Inc.

Specialty Business Services

IndustrialsNYSE • US
Market Cap$3.64B
5Y Perf.-7.4%
CACI
CACI International Inc

Information Technology Services

TechnologyNYSE • US
Market Cap$10.82B
5Y Perf.+95.4%

MMS vs CACI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MMS logoMMS
CACI logoCACI
IndustrySpecialty Business ServicesInformation Technology Services
Market Cap$3.64B$10.82B
Revenue (TTM)$5.32B$9.16B
Net Income (TTM)$373M$537M
Gross Margin24.6%14.9%
Operating Margin10.8%9.3%
Forward P/E7.8x17.4x
Total Debt$1.44B$3.34B
Cash & Equiv.$260M$106M

MMS vs CACILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MMS
CACI
StockMay 20May 26Return
Maximus, Inc. (MMS)10092.6-7.4%
CACI International … (CACI)100195.4+95.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: MMS vs CACI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MMS leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. CACI International Inc is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MMS
Maximus, Inc.
The Value Pick

MMS carries the broadest edge in this set and is the clearest fit for valuation efficiency.

  • PEG 0.77 vs CACI's 1.44
  • Lower P/E (7.8x vs 17.4x), PEG 0.77 vs 1.44
  • 7.0% margin vs CACI's 5.9%
Best for: valuation efficiency
CACI
CACI International Inc
The Income Pick

CACI is the clearest fit if your priority is income & stability and growth exposure.

  • beta 0.30
  • Rev growth 12.6%, EPS growth 20.0%, 3Y rev CAGR 11.6%
  • 416.4% 10Y total return vs MMS's 39.7%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCACI logoCACI12.6% revenue growth vs MMS's 2.4%
ValueMMS logoMMSLower P/E (7.8x vs 17.4x), PEG 0.77 vs 1.44
Quality / MarginsMMS logoMMS7.0% margin vs CACI's 5.9%
Stability / SafetyCACI logoCACIBeta 0.30 vs MMS's 0.72, lower leverage
DividendsMMS logoMMS1.8% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CACI logoCACI+3.3% vs MMS's +1.1%
Efficiency (ROA)MMS logoMMS8.8% ROA vs CACI's 5.7%, ROIC 15.1% vs 9.2%

MMS vs CACI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MMSMaximus, Inc.
FY 2025
Clinical Services
86.6%$2.1B
Advanced Technology Solutions
13.4%$325M
CACICACI International Inc
FY 2025
Technology Service
55.4%$4.8B
Service, Other
44.6%$3.8B

MMS vs CACI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMMSLAGGINGCACI

Income & Cash Flow (Last 12 Months)

MMS leads this category, winning 4 of 6 comparable metrics.

CACI is the larger business by revenue, generating $9.2B annually — 1.7x MMS's $5.3B. Profitability is closely matched — net margins range from 7.0% (MMS) to 5.9% (CACI). On growth, CACI holds the edge at +8.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
RevenueTrailing 12 months$5.3B$9.2B
EBITDAEarnings before interest/tax$645M$1.1B
Net IncomeAfter-tax profit$373M$537M
Free Cash FlowCash after capex$372M$470M
Gross MarginGross profit ÷ Revenue+24.6%+14.9%
Operating MarginEBIT ÷ Revenue+10.8%+9.3%
Net MarginNet income ÷ Revenue+7.0%+5.9%
FCF MarginFCF ÷ Revenue+7.0%+5.1%
Rev. Growth (YoY)Latest quarter vs prior year-4.1%+8.5%
EPS Growth (YoY)Latest quarter vs prior year+6.5%+17.8%
MMS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MMS leads this category, winning 7 of 7 comparable metrics.

At 12.1x trailing earnings, MMS trades at a 45% valuation discount to CACI's 22.0x P/E. Adjusting for growth (PEG ratio), MMS offers better value at 1.19x vs CACI's 1.81x — a lower PEG means you pay less per unit of expected earnings growth.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
Market CapShares × price$3.6B$10.8B
Enterprise ValueMkt cap + debt − cash$4.8B$14.1B
Trailing P/EPrice ÷ TTM EPS12.10x21.95x
Forward P/EPrice ÷ next-FY EPS est.7.83x17.37x
PEG RatioP/E ÷ EPS growth rate1.19x1.81x
EV / EBITDAEnterprise value multiple6.67x14.65x
Price / SalesMarket cap ÷ Revenue0.67x1.25x
Price / BookPrice ÷ Book value/share2.31x2.82x
Price / FCFMarket cap ÷ FCF9.93x22.48x
MMS leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

MMS leads this category, winning 8 of 9 comparable metrics.

MMS delivers a 21.8% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $13 for CACI. CACI carries lower financial leverage with a 0.86x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMS's 0.86x. On the Piotroski fundamental quality scale (0–9), MMS scores 8/9 vs CACI's 7/9, reflecting strong financial health.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
ROE (TTM)Return on equity+21.8%+13.1%
ROA (TTM)Return on assets+8.8%+5.7%
ROICReturn on invested capital+15.1%+9.2%
ROCEReturn on capital employed+17.4%+11.6%
Piotroski ScoreFundamental quality 0–987
Debt / EquityFinancial leverage0.86x0.86x
Net DebtTotal debt minus cash$1.2B$3.2B
Cash & Equiv.Liquid assets$260M$106M
Total DebtShort + long-term debt$1.4B$3.3B
Interest CoverageEBIT ÷ Interest expense4.93x4.52x
MMS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CACI leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CACI five years ago would be worth $18,540 today (with dividends reinvested), compared to $7,958 for MMS. Over the past 12 months, CACI leads with a +3.3% total return vs MMS's +1.1%. The 3-year compound annual growth rate (CAGR) favors CACI at 17.3% vs MMS's -4.0% — a key indicator of consistent wealth creation.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
YTD ReturnYear-to-date-22.5%-8.8%
1-Year ReturnPast 12 months+1.1%+3.3%
3-Year ReturnCumulative with dividends-11.6%+61.2%
5-Year ReturnCumulative with dividends-20.4%+85.4%
10-Year ReturnCumulative with dividends+39.7%+416.4%
CAGR (3Y)Annualised 3-year return-4.0%+17.3%
CACI leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CACI leads this category, winning 2 of 2 comparable metrics.

CACI is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than MMS's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CACI currently trades 71.7% from its 52-week high vs MMS's 66.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
Beta (5Y)Sensitivity to S&P 5000.72x0.30x
52-Week HighHighest price in past year$100.00$683.50
52-Week LowLowest price in past year$60.75$409.62
% of 52W HighCurrent price vs 52-week peak+66.7%+71.7%
RSI (14)Momentum oscillator 0–10035.036.4
Avg Volume (50D)Average daily shares traded683K270K
CACI leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates MMS as "Buy" and CACI as "Buy". Consensus price targets imply 65.0% upside for MMS (target: $110) vs 48.1% for CACI (target: $726). MMS is the only dividend payer here at 1.78% yield — a key consideration for income-focused portfolios.

MetricMMS logoMMSMaximus, Inc.CACI logoCACICACI Internationa…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$110.00$725.50
# AnalystsCovering analysts1629
Dividend YieldAnnual dividend ÷ price+1.8%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$1.19
Buyback YieldShare repurchases ÷ mkt cap+12.3%+1.6%
Insufficient data to determine a leader in this category.
Key Takeaway

MMS leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CACI leads in 2 (Total Returns, Risk & Volatility).

Best OverallMaximus, Inc. (MMS)Leads 3 of 6 categories
Loading custom metrics...

MMS vs CACI: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MMS or CACI a better buy right now?

For growth investors, CACI International Inc (CACI) is the stronger pick with 12.

6% revenue growth year-over-year, versus 2. 4% for Maximus, Inc. (MMS). Maximus, Inc. (MMS) offers the better valuation at 12. 1x trailing P/E (7. 8x forward), making it the more compelling value choice. Analysts rate Maximus, Inc. (MMS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MMS or CACI?

On trailing P/E, Maximus, Inc.

(MMS) is the cheapest at 12. 1x versus CACI International Inc at 22. 0x. On forward P/E, Maximus, Inc. is actually cheaper at 7. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Maximus, Inc. wins at 0. 77x versus CACI International Inc's 1. 44x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — MMS or CACI?

Over the past 5 years, CACI International Inc (CACI) delivered a total return of +85.

4%, compared to -20. 4% for Maximus, Inc. (MMS). Over 10 years, the gap is even starker: CACI returned +416. 4% versus MMS's +39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MMS or CACI?

By beta (market sensitivity over 5 years), CACI International Inc (CACI) is the lower-risk stock at 0.

30β versus Maximus, Inc. 's 0. 72β — meaning MMS is approximately 144% more volatile than CACI relative to the S&P 500. On balance sheet safety, CACI International Inc (CACI) carries a lower debt/equity ratio of 86% versus 86% for Maximus, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MMS or CACI?

By revenue growth (latest reported year), CACI International Inc (CACI) is pulling ahead at 12.

6% versus 2. 4% for Maximus, Inc. (MMS). On earnings-per-share growth, the picture is similar: CACI International Inc grew EPS 20. 0% year-over-year, compared to 10. 4% for Maximus, Inc.. Over a 3-year CAGR, CACI leads at 11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MMS or CACI?

Maximus, Inc.

(MMS) is the more profitable company, earning 5. 9% net margin versus 5. 8% for CACI International Inc — meaning it keeps 5. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMS leads at 10. 6% versus 8. 9% for CACI. At the gross margin level — before operating expenses — MMS leads at 23. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MMS or CACI more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Maximus, Inc. (MMS) is the more undervalued stock at a PEG of 0. 77x versus CACI International Inc's 1. 44x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Maximus, Inc. (MMS) trades at 7. 8x forward P/E versus 17. 4x for CACI International Inc — 9. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 65. 0% to $110. 00.

08

Which pays a better dividend — MMS or CACI?

In this comparison, MMS (1.

8% yield) pays a dividend. CACI does not pay a meaningful dividend and should not be held primarily for income.

09

Is MMS or CACI better for a retirement portfolio?

For long-horizon retirement investors, CACI International Inc (CACI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

30), +416. 4% 10Y return). Both have compounded well over 10 years (CACI: +416. 4%, MMS: +39. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MMS and CACI?

These companies operate in different sectors (MMS (Industrials) and CACI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MMS is a small-cap deep-value stock; CACI is a mid-cap quality compounder stock. MMS pays a dividend while CACI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MMS

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

CACI

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MMS and CACI on the metrics below

Revenue Growth>
%
(MMS: -4.1% · CACI: 8.5%)
Net Margin>
%
(MMS: 7.0% · CACI: 5.9%)
P/E Ratio<
x
(MMS: 12.1x · CACI: 22.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.